BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.41 Cr | ₹4.36 Cr | ₹2.67 Cr | ₹2.69 Cr | ₹1.07 Cr |
What is the latest Long Term Provisions ratio of BLISS GVS PHARMA ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹3.41 Cr |
| Mar2025 | ₹4.36 Cr |
| Mar2024 | ₹2.67 Cr |
| Mar2023 | ₹2.69 Cr |
| Mar2022 | ₹1.07 Cr |
How is Long Term Provisions of BLISS GVS PHARMA Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.41 Cr | -21.88 | |
| Mar2025 | ₹4.36 Cr | 63.20 | |
| Mar2024 | ₹2.67 Cr | -0.56 | |
| Mar2023 | ₹2.69 Cr | 150.37 | |
| Mar2022 | ₹1.07 Cr | - | |
Compare Long Term Provisions of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹7,273.0 Cr | 1.4% | 12.8% | 369% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 1.4% |
12.8% |
369% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses